2021
DOI: 10.1261/rna.078694.121
|View full text |Cite
|
Sign up to set email alerts
|

A noncanonical microRNA derived from the snaR-A noncoding RNA targets a metastasis inhibitor

Abstract: MicroRNAs (miRNAs) are small noncoding RNAs that function as critical posttranscriptional regulators in various biological processes. While most miRNAs are generated from processing of long primary transcripts via sequential Drosha and Dicer cleavage, some miRNAs that bypass Drosha cleavage can be transcribed as part of another small noncoding RNA. Here, we develop the target-oriented miRNA discovery (TOMiD) bioinformatic analysis method to identify Drosha-independent miRNAs from Argonaute crosslinking and seq… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 72 publications
2
15
0
Order By: Relevance
“…S1B). As expected, in data sets obtained from DROSHA KO cells, we observed enrichment of hybrids containing Drosha-independent miRNAs including TSS-miRNAs (miR-320a and miR-484), mirtron (miR-877), and the recently described miR-snaR, a non-canonical miRNA derived from non-coding RNA snaR-A (Table S2) (48). MiR-320acontaining hybrids are far more abundant than other Drosha-independent miRNAs, making up to 74.58% of all the miRNA/mRNA hybrids in qCLASH data (Table S2).…”
Section: Comparison Of Clash Qclash and Mirna-specific Qclashsupporting
confidence: 83%
See 2 more Smart Citations
“…S1B). As expected, in data sets obtained from DROSHA KO cells, we observed enrichment of hybrids containing Drosha-independent miRNAs including TSS-miRNAs (miR-320a and miR-484), mirtron (miR-877), and the recently described miR-snaR, a non-canonical miRNA derived from non-coding RNA snaR-A (Table S2) (48). MiR-320acontaining hybrids are far more abundant than other Drosha-independent miRNAs, making up to 74.58% of all the miRNA/mRNA hybrids in qCLASH data (Table S2).…”
Section: Comparison Of Clash Qclash and Mirna-specific Qclashsupporting
confidence: 83%
“…Because the 5′ and 3′ adapters contain degenerate nucleotides to account for PCR bias and minimize ligation preferences (44), we collapsed duplicate reads using the FASTX-Toolkit FASTQ Collapser, and the degenerate nucleotides were removed using Cutadapt (45,46). Chimeric reads (hybrids) were identified using the Hyb software with the default database supplemented with previously identified TSS-miRNAs and miR-snaR (20,47,48). With viennad-format files output from Hyb, we used a custom script to identify overlapping targets for specific miRNAs.…”
Section: Clash For Mirna Target Identification In Hct116 Cellsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, it is possible to identify cases in which both types of molecule (piRNA and other sncRNAs) could be bifunctional and even suggest alternative regulatory mechanisms to generate one or the other type. In fact, alternative, non-canonical pathways in the biogenesis of miRNAs have been reported [ 18 20 ]. Here, we evaluate that possibility for miRNAs/piRNAs from precursors that might generate such a situation.…”
Section: Utility and Discussionmentioning
confidence: 99%
“…While this protocol was developed to study KSHV, EBV, and MHV-68 miRNA targetomes, it has already been applied to nonviral cancers such as metastatic melanoma (Bullard et al, 2019;Gay et al, 2018;Kozar et al, 2021;Ungerleider et al, 2020). Moreover, in combination with innovative bioinformatic approaches, qCLASH has identified a novel human miRNA called miR-SNAR that is up-regulated in breast cancer cells and regulates migration (Stribling et al, 2021). In summary, this protocol simplifies the application of state-of-the-art ribonomics methods to identify high-confidence miRNA targetomes in disease-relevant models and tissues.…”
Section: Commentary Background Informationmentioning
confidence: 99%